Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Kaigene Enters Exclusive Licensing Agreement with Taisho for KG006 Development in Japan

Jul 31, 2026•9 days ago

Contract Type

agreement

BethesdaBiotechnology

Description

Kaigene Inc. has secured an exclusive licensing agreement with Taisho Pharmaceutical Co., Ltd. for the development and commercialization of KG006 in Japan. This partnership is expected to enhance Taisho's autoimmune portfolio and provide Kaigene with optimal local support for market entry.

Company Information

Company

Kaigene

Location

Bethesda, Maryland, United States

Predictive Intelligence
Strategic

ML-powered predictions for Kaigene's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.